1 |
南岩东,房延凤,姜华,等. 基于免疫组化法分析肺腺癌S100A6蛋白表达与临床特征的关系[J/CD]. 中华肺部疾病杂志(电子版), 2017, 10(1): 15-19.
|
2 |
Ji YF, Huang H, Jiang F, et al. S100 family signaling network and related proteins in pancreatic cancer[J]. Int J Mol Med, 2014, 33 (4): 769-776.
|
3 |
Nan Y, Jin F, Yang S, et al. Discovery of a set of biomarkers of human lung adenocarcinoma through cell-map proteomics and bioinformatics[J]. Med Oncol, 2010, 27(4): 1398-1406.
|
4 |
Shen J, Xie Y, Sun ML, et al. Antitumor activity of cobrotoxin in human lung adenocarcinoma A549 cells and following transplantation in nude mice[J]. Oncol Lett, 2014, 8(5): 1961-1965.
|
5 |
Sato Y, Harada K, Sasaki M, et al. Clinicopathological significance of S100 protein expression in cholangiocarcinoma[J]. J Gastroenterol Hepatol, 2013, 28(8): 1422-1429.
|
6 |
Ishii A, Suzuki M, Satomi K, et al. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression[J]. Pathol Int, 2009, 59(9): 623-630.
|
7 |
Stradal TB, Gimona M. Ca(2+)-dependent association of S100A6 (Calcyclin) with the plasma membrane and the nuclear envelope[J]. J Biol Chem, 1999, 274(44):31593-31596.
|
8 |
Nowomy M, Bhattacharya S, Filipek A, et al. Characterization of the interaction of calcyclin(S100A6)and calcyclin binding protein[J]. J Bio1 Chem, 2000, 275(40): 31178-31182.
|
9 |
Ilg EC, Schafer BW, Heizmann CW. Expression pattern of S100 calcium-binding proteins in human tumors[J]. Int J Cancer, 1996, 68 (3): 325-332.
|
10 |
南岩东,常蕊静,穆德广,等. 肿瘤相关蛋白质S100A6结构和功能的分析与预测[J]. 现代肿瘤医学,2013, 21(6): 1180-1184.
|
11 |
南岩东,马李杰,金发光,等. EF手型钙结合蛋白S100A6及其与肿瘤关系的研究进展[J]. 国际呼吸杂志,2014, 34 (20):1561-1565.
|
12 |
Yamaguchi H, Hanawa H, Uchida N, et al. Multi step pathogenesis of leukemia via the MLL-AF4 chimericgene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement o f S100A6 expression[J]. Exp Hematol, 2009, 37(6): 701-714.
|
13 |
Somnicki LP, Le′sniak W. S100A6 (calcyclin) deficiency induce ssenescence like changes in cell cycle, morphology and functional characteristics of mouse NIH3T3 fibroblasts[J]. J Cell Biochem, 2010, 109(3): 576-584.
|
14 |
Matsumoto T, Murao S, Kito K, et al. Modulation of S100 genes response to growth conditions in human epithelial tumor cells[J]. Pathol Int, 1997, 47(6): 339-346.
|
15 |
Tsoporis JN, Izhar S, Parker TG. Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha[J]. J Biol Chem, 2008, 283(44): 30174-30183.
|
16 |
Leśniak W, Słomnicki ŁP, Filipek A. S100A6-new facts and features[J]. Biochem Biophys Res Commun, 2009, 390(4): 1087-1092.
|
17 |
Króliczak W, Pietrzak M, Puzianowska-Kuznicka M. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB[J]. Acta Biochim Pol, 2008, 55(3): 559-570.
|
18 |
Fernandez-Fernandez MR, Rutherford TJ, Fersht AR. Members of the S100 family bind p53 in two distinct ways[J]. Protein Sci, 2008, 17(10): 1663-1670.
|
19 |
Słomnicki ŁP, Nawrot B, Leśniak W. S100A6 binds p53 and affects its activity[J]. Int J Biochem Cell Biol, 2009, 41(4): 784-790.
|